We work across a wide range of biotech areas including immunotherapeutics and vaccines, molecular diagnostics, bio-therapeutics, microbial technologies, transgenic plants and plant varieties.
Protecting and commercialising biotechnology inventions is particularly demanding given the differences between jurisdictions. The Fisher Adams Kelly Callinans team knows the intricacies of these variances, particularly in relation to what can be patented and the regulatory regimes that govern approval, marketing and sale of biotechnology products.
Our team of biotechnology patent attorneys are particularly skilled in guiding early stage biotechnology inventions through the patent process in Australia and overseas jurisdictions, with a constant eye on wider patent strategy and the end commercial gain. This strategic focus maintains the best overall commercial advantage for the client.
Further, our team of specialist trade marks attorneys has an in-depth understanding of trade mark issues that may arise in relation to biotechnology products and services in Australia and overseas jurisdictions, including the use of International Nonproprietary Names (INNs) and INN stems in trade marks for pharmaceuticals or veterinary substances, and trade marks containing plant variety names. Protecting brands in this way can be vital to maintaining profitability for research effort beyond the expiration of a patent, and our team understand what is required to support this aim.
We work with a diverse range of organisations within the biotechnology industry including start-ups, small biotech companies, universities, research institutes, hospitals, and national and multinational corporations.
It would be our pleasure to discuss how we can protect and maximise the commercial value of your biotechnology innovations and brands.
Please contact us today and one of our team will promptly respond to your inquiry.